ClinicalTrialsFinder

MET Exon 14 Mutation Clinical Trials in Besançon

1 recruitingBesançon, France

Showing 1–1 of 1 trials

Recruiting
Phase 3

Tepotinib vs Standard Treatment in Patients With Advanced MET Exon 14 Mutated Non-Small Cell Lung Cancer Previously Treated

Advanced Non-Small Cell Lung CancerMET Exon 14 Mutation
Intergroupe Francophone de Cancerologie Thoracique133 enrolled29 locationsNCT06908993